The importance of the glucose transporter isoform, GLUT2, in the const
ruction of glucose-sensitive surrogate insulin-secreting cells was eva
luated using murine pituitary AtT20 cells. The cells were double trans
fected with cDNAs for human preproinsulin (hppI-1) driven by the cytom
egalovirus promoter, and human GLUT2 driven by the beta-actin promoter
. The stably transfected clone, AtTinsGLUT2.36, which strongly express
ed both the hppI-1 and GLUT2 genes, constitutively released 7.5 ng/10(
6) cells/24 h of immunoreactive insulin-like material, 75% of which wa
s fully processed mature human insulin. Increasing glucose concentrati
ons in the subphysiological range up to 50 mu M increased insulin rele
ase; but greater glucose concentrations did not further increase insul
in release. Suppression of the low-K-m glucose-phosphorylating enzyme,
hexokinase, with 2-deoxy-D-glucose increased glucose-stimulated insul
in release by two- to threefold in the presence of subphysiological an
d physiological glucose concentrations up to 10 mM. Physiological gluc
ose concentrations increased the amount of GLUT2 mRNA, indicating that
the beta-actin promoter responds in a glucose-dependent manner. Impla
ntation of 2 x 10(7) AtTinsGLUT2.36 cells intraperitoneally into strep
tozotocin-diabetic nude mice slowed the progression of hyperglycaemia.
The implanted cells formed vascularised tumourlike cell aggregates at
tached to the peritoneum. The results demonstrate that the beta-actin
promoter is partially regulated by glucose. Expression of GLUT2 enable
s glucose to enter the cell at high K-m, but high-K-m glucose phosphor
ylation is also required to signal glucose-stimulated genes affecting
insulin release.